Items Tagged ‘dementia’
August 23, 2021
Mayo Clinic Research in the news — 8/23/2021
By Advancing the Science contributor 
In the last 15 days or so, COVID-19 related news continues to dominate the headlines on the research front. However, Mayo Clinic’s expertise also was evident on topics from inclusivity in clinical trials, a geological connection in kidney stones, life extending therapies and better understanding of contributors to dementia, stroke and death. Read on for […]
Tags: brain, clinical trials, cognitive impairment, COVID-19, dementia, diversity, health disparities, hypertension, idiopathic pulmonary fibrosis, immune system, kidney stones, knee replacement
August 10, 2021
Mayo Clinic Research in the news — 8/9/2021
By Advancing the Science contributor
COVID-19 has once again taken almost all the headlines. However, research and expertise across the vastness of medicine still continues. Those stories are at the top — dancing after menopause, hemp seeds for inflammation, ‘brain orgasms’, and more. Then read on for the latest understanding in why the delta variant spreads even among vaccinated people, […]
Tags: Abinash Virk, Ala Dababneh, Angela Dispenzieri, antibodies, arthritis, Arya Mohabbat, cancer, cardiology, chemotherapy, COVID-19, dementia, Devang Sanghavi
July 26, 2021
Mayo Clinic Research in the news — 7/26/2021
By Advancing the Science contributor
Mayo Clinic expertise has a consistent footprint in the news in 2021. This week’s topics include data security and interoperability; some lesser discussed COVID-19 related topics: language development, booster vaccines for immunocompromised individuals, portable air filters; as well as early onset dementia, and the need for diversity among bone marrow donors. Vaccines are highy unlikely […]
Tags: Aaron Krych, acute kidney injury, Ahmad Nassr, antibodies, arthritis, artificial intelligence, big data, biomarkers, bone marrow transplant, Brian Weinshenker, Bruce Johnson, Bruce Sutor
July 14, 2021
Mayo Clinic research in the news — 7/12/2021
By Advancing the Science contributor
Research and expertise from Mayo Clinic have been in the news on topics from marijuana, sleep, disparities, dementia and doses of vaccine. Read more. New York Times, Can Marijuana Make You a Better Athlete? … “If you look at any test of physical performance, there’s either no data, it’s a wash, or marijuana makes it worse,” […]
Tags: addiction research, alcoholism, Alejandro Rabinstein, Alyx Porter, Alzheimer's disease, artificial intelligence, autoimmune disorder, Bhanu Kolla, breast cancer, cancer vaccine, cardiology, Center for Individualized Medicine
May 10, 2021
Mayo Clinic Research in the news — 5/10/2021
Some Mayo Clinic research in the news this week is at the discovery level, in our genes. And at the other end of the research spectrum, better outcomes in a clinical setting — in this case, a new way to heal scars. Read the post for quick stops all along the continuum, including trauma, COVID-19, […]
Tags: Alzheimer's disease, artificial intelligence, big data, brain, Brian Kim, cancer prevention, cancer screening, Chyke Doubeni, clinical trials, colorectal cancer, data science, dementia
March 15, 2021
Mayo Clinic Research in the news — 3/15/2021
News stories this week about Mayo Clinic research and highlighting researchers cover several topics including research education, examining the retina to detect dementia, lumbar punctures and opioid management. State leaders stress the importance of phase II of Prairie Springs Science Center WXOW, 3/9/2021 Seven state leaders gathered at UW-La Crosse’s Crowley Hall Tuesday morning to […]
Tags: Alzheimer's disease, Amy Oxentenko, cancer, Center for Clinical and Translational Science, clinical trials, COVID-19, David Knopman, dementia, Derek Johnson, diabetes, Mayo Clinic Alix School of Medicine, Mayo Clinic Health System
March 8, 2021
Mayo Clinic Research in the news — 3/8/2021
By Advancing the Science contributor
In Mayo Clinic research news over the past seven days, the headlines covered medical marijuana, systemic racism, Alzheimer’s, and a range of other topics including COVID-19. Minnesota Senate bill could increase spinal cord research funding, KSTP, 3/4/2021 This $285 eye scan may someday detect Alzheimer’s risk. (It also requires plenty of curry flavoring.), Advisory Board, […]
Tags: ADHD, aging, Alzheimer's disease, biomarkers, cholesterol, clinical trials, colorectal cancer, COVID-19, dementia, health care systems engineering, health disparities, lymphoma
February 8, 2021
Mayo Clinic Research in the news — 2/8/2021
In the week’s news, you can find expertise from Mayo Clinic clinicians and researchers on a range of topics, including several different heart conditions, a blood test for Alzheimer’s, cancer, disparities in diabetes care, and of course COVID-19. Expertise from a Mayo Clinic International consultant is also highlighted, along with Michael Camilleri, M.D., who received […]
Tags: Alzheimer's disease, artificial intelligence, Bart Demaerschalk, blood cancer, blood disease, blood test, breast cancer, cardiology, cardiovascular disease, caregivers, Center for Digital Health, Center for the Science of Health Care Delivery
January 25, 2021
Mayo Clinic Research in the news — 1/25/2021
From acupuncture, breast cancer, diabetes, euthyroid … all the way to Zika, Mayo Clinic research and experts are featured in the news. Also find COVID-19 observations, advice and findings. The Rochester Epidemiology Project: “The greatest medical resource you’ve never heard of” Rochester Magazine, 1/22/2021 The Rochester Epidemiology Project has changed the way we view ADHD. […]
Tags: acupuncture, acute flaccid myelitis, ADHD, Alzheimer's disease, amyloidosis, artificial intelligence, biomarkers, breast cancer, Brent Bauer, cancer, cancer genomics, cannabidiol (CBD)
December 7, 2020
Mayo Clinic Research in the news — 12/7/2020
Lots of chatter last week on COVID-19 and the pending arrival of a vaccine(s). Our researchers and clinicians agree that vaccines are a useful part of our toolbox for fighting infectious disease, and have high hopes for effective reduction of the risks of COVID-19 through widespread vaccination. Other research that made the top of the […]
Tags: Alfredo Quinones-Hinojosa, Alzheimer's disease, artificial intelligence, cancer, Center for the Science of Health Care Delivery, clinical trials, COVID-19, dementia, Erin Barreto, Gregory Poland, infectious disease, Kern Health Care Delivery Scholars